1 – 10 of 242
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
- Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
- Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
- Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer
- High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
- Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
- Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
- The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
- The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
- The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype